| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5574403 | Journal of Stroke and Cerebrovascular Diseases | 2017 | 6 Pages |
Abstract
The SAMe-TT2R2 tool is effective in predicting warfarin control in a Singaporean population as patients with a score greater than 2 had poor control. The minimum score for non-Caucasian patients is 2; thus, in these patients, the presence of any additional risk factors identified in the SAMe-TT2R2 tool categorizes them as unlikely to achieve adequate warfarin control and possible candidates for alternative anticoagulants.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Nijole B Pharm, Chi Keong MBBS, MRCP(UK), FAMS(Cardiology), Liping BSc(Pharmacy), Jin Shing BSc(Pharmacy), Siew Chong B Pharm, Andrew K. PhD, Shailendra PhD,